Drug Res (Stuttg) 2020; 70(06): 257-264
DOI: 10.1055/a-1147-5724
Original Article

Trigonelline Demonstrated Ameliorative Effects in Dexamethasone Induced Osteoporotic Rats

Akshoo Rathi
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Mohd Ishaq
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Abul Kalam Najmi
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Mohd Akhtar
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
› Author Affiliations

Abstract

Aim Trigonelline is a potent phytochemical present in fenugreek, which has strong anti-oxidant and phytoestrogenic activities. This study was carried out to investigate this estrogenic activity as a possible mechanisms involved in preventing the symptoms of osteoporosis in dexamethasone induced osteoporosis in rats.

Materials and Methods Wistar rats were randomly divided into eight groups, six animals in each group. Osteoporosis was induced using dexamethasone 0.1mg/kg subcutaneously in rats for three times per week for 8 consecutive weeks and treatment with drugs up to 12 weeks as per the treatment schedule described. After 12 weeks, rats were sacrificed; blood samples were collected from each rat and the clear, non hemolysed supernatant sera was used for biochemical examinations. Femurs were used for Bone Mineral Density (BMD), microcomputed tomography (Micro CT), histology and biochemical examinations.

Results BMD, bone micro structure, serum calcium, phosphorus level and serum estradiol levels were decreased while serum PTH levels, SAP and acid phosphatase (ACP) were elevated in dexamethasone treated rats as compared to control (p<0.01). Dexmethasone treated animals showed loss of marrow at multifocal area, cartilage and trabeculae and thinning of trabeculae (bone resorption), zone of cartilage was poorly seen and fat cells in marrow. Trigonelline showed significant improvement and prevent the progression of osteoporosis by enhancing the BMD, restoring bone physiology.

Conclusion Our results confirm the estrogenic activity of triogonelline, which is responsible for its effects; still, it needs further evaluation in other animal models to provide a more conclusive view for its therapeutic usefulness in osteoporosis.



Publication History

Received: 03 March 2020

Accepted: 23 March 2020

Article published online:
14 April 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Mcleod KatherineM., Shanthi Johnson C. A Systemic review of osteoporosis health beliefs in men and women. Journal of Osteoporosis. 2011; DOI: 11 http://dx.doi.org/10.4061/2011/197454
  • 2 Hernlund E, Svedbom A, Ivergard M. et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporosis 2013; 8: 136
  • 3 Vito Pavone, Gianluca Testa, Serena MC.Giardia. et al. Pharmacological Therapy of Osteoporosis: A Systematic current review of Literature. Frontiers Pharmacology 2017; 8: 1-7
  • 4 Das Subhajit, Crockett JulieC. Osteoporosis- a current view of pharmacological prevention and treatment. Drug Design Development Therapy 2013; 5: 435-448
  • 5 Fraser Lisa-Ann, Adachi JonathanD.. Glucocorticoid-induced osteoporosis: Treatment update and review. Therapeutic Advances Musculoskeletal Disease 2009; 1: 71-85
  • 6 Vijaya CL, Banji D, Banji JF. et al. A review on glucocorticoid induced osteoporosis. International Journal Pharmaceutical Sciences Review and Research 2010; 5: 124-131
  • 7 LoCascio V, Bonucci E, Imbimbo B. et al. Bone loss in response to long-term glucocorticoid therapy. J Bone Mineral 1990; 8: 39-51
  • 8 Lukert BP, Raisz LG. Glucocorticoid induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352-364
  • 9 Buckley L, Greenwald M, Hochberg M. et al. Recommendation for the prevention and treatment of glucorticoid-induced osteoporosis. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis 2001; 44: 1496-1503
  • 10 Kalervo Vaananen H, Harkonen PL. Estrogen and bone metabolism. MATURITAS, Journal of the Climacteric and Postmenopause 1996; 23S: S65-S69
  • 11 Riis BenteJuel, Robro Paul, Christiansen Claus. The role of serum concentration of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcified Tissue International 1986; 38: 318-322
  • 12 Lawrence GR. A Review on Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. The Journal of Clinical Investigation 2017; 115: 3318-3325
  • 13 Dalais FS, Rice GE, Wablqvist ML. et al. Effect of dietary phytoestrogens in postmenopausal women. Climacteric 1981; 124-129
  • 14 She-Fang YeI, Saga K, Ichimura M. et al. Coumestrol as well as isoflavones in soyabean extract prevent bone resorption in ovariectomized rats. Endocrine Regulations 2003; 37: 145-152
  • 15 Folwarczna J, Zych M, Nowinska B. et al. Effects of fenugreek seed on bone mechanical properties of rats. European Review Medical and Pharmacological Sciences 2014; 18: 1937-1947
  • 16 Folwarczna J, Zych M, Nowinska B. et al. Unfavorable effects of trigonelline, an alkaloid present in coffee and fenugreek on bone mechanical properties in estrogen deficient rats. Mol Nutr Res 2014; 58: 1457-1464
  • 17 Alcantara EH, Shin MY, Sohn HY. et al. Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone specific transcription factor Runnx2 in osteoblastic MC3T3-E1 cells. J Nutrition Biochem 2011; 22: 1055-1063
  • 18 Satheeshkumar N, Mukherjee PK, Bhadra S. et al. Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituent. Phytomedicine 2010; 17: 292-295
  • 19 Dixit P, Ghaskadbi S. Hari Mohan and Thomas PA. Devasagayam. Antioxidant properties of germinated fenugreek seeds. Phototherapy. Research 2010; 19: 977-983
  • 20 Xue Wanli, Lei Jing, Li Xuanshe. et al. Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutrition Research 2011; 31: 555-562
  • 21 Jette L, Harvey L, Eugeni K. et al. 4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndrome. Curr Opin Investig Drugs 2009; 10: 353-358
  • 22 Zhou J, Chan L, Zhou S. Trigonelline: A plant alkaloid with therapeutic potential for potential for diabetes and central nervous system disease. Current Medicinal Chemistry 2012; 19: 3523-3531
  • 23 Acharya SN, Thomas JE, Basu SK. Fenugreek, an alternative crop for semiarid regions of North America. Crop Sci 2008; 48: 841-853
  • 24 Wang C, Li H, Chen SG. et al. The skeletal effects of thiazolidinedione and metformin on insulin- resistant mice. J Bone Miner Metab 2012; 30: 630-637
  • 25 Allred KF, Yackley KM, Vanamala J. et al. Trigonelline is a novel phytoestrogen in coffee beans. J Nutr 2009; 139: 1833-1838
  • 26 Aswar U, Mohan V, Bodhankar SL. Effect of trigonelline on fertility in female rats. International Journal of Green Pharmacy 2009; 220-223
  • 27 Hozayen G, Walla A, EL-Desouky Mohamed A. et al. Antiosteoporotic effect of Petrolinum crispum, Ocimum Basilicum and Cichorium intybus L. in glucocorticoid- induced osteoporosis in rats. BMC Complementary and Alternative Medicine 2016; 16: 1
  • 28 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2007; 22: 659-661
  • 29 Estanislau CA, Rahal SC, Muller SS. et al. Evaluation of femur of orchiectomized guinea pigs by bone densitometry using dual-energy X-ray absorptiometry (DXA) and mechanical testing. Vet and Zootec 2010; 17: 104-112
  • 30 Ahmad N, Venkatesh TB, Kushwaha P. et al. Quercetin loaded solid lipid nanoparticles improves Osteoprotective activity in ovariectomized Rat Model: A preventive strategy for post-menopausal osteoporosis. RSC Adv. 2016; 6: 97613-97628
  • 31 Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. American Journal of Clinical Pathology 1966; 45: 290-296
  • 32 John A. Daly and Gerhard Ertingshausen. Direct method for determining inorganic phosphate in serum with the “CentrifiChem”. Clinical Chemistry 1972; 18: 263-265
  • 33 Hans-Jurgen S, Gerhard G. Georg Wideral and Hubert Mayer. Nucleotide sequence of a full-length cDNA clone encoding preproparathyroid hormone from pig and rat. Nucleic Acids Research 1987; 15: 6740
  • 34 Pentti K, Siiteri JT, Geoffrey LM. et al. The serum transport of steroid hormones. Recent Progress in Hormone Research 1982; 38: 457-510
  • 35 Mary F, Massod BS, Ascp MT. et al. Kinetic determination of serum alkaline phosphatase activity. American Journal Clinical Pathology 1970; 54: 110-117
  • 36 Tenniswood M, Bird CE, Clark AF. Acid phosphate: Androgen markers of rat prostate. Can J Biochem 1976; 54
  • 37 Zhou Da-An, Zheng Hong-Xin, Wang Chen-Wen. et al. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. BMC Musculoskeletal Disorder 2014; 15: 239
  • 38 Kaushik AnjanP, Das Anusuya, Cui Quanjun. Osteonecrosis of the femoral head: An update in year 2012. World Journal of Orthopedics. 2012: 49-57
  • 39 Dickey RP, Taylor SN, Curole DN. Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone. Fertil Steril 1984; 42 Suppl 5: 709-716
  • 40 Borai IH, Wafay HA, ARB AbdelGhaffa. et al. The protective effect of nondigestible oligosaccharides from chicory roots and phyto soya extract on osteoporosis in rats. Australian. Journal of Basics and Applied Science 2009; 3: 970-976
  • 41 Omara EnayatA, Shaffie NermeenM., Et-Toumy SayedA.. et al. Histomorphometric evaluation of bone tissue exposed to experimental osteoporosis and treated with Ratama Raetam Extract. Journal of Applied Science Research 2009; 706-716
  • 42 Jalva T, Sarna S, Nen LP. et al. Association Between Vertebral Fracture and Increased Mortality in Osteoporotic Patients. J Bone Min Res 2003; 18: 1254-1260
  • 43 Carballido-Gamio Julio, Sharmila M. Clinical utility of microarchitecture measurement of trabecular bone. Current Osteoporosis Reports 2006; 4: 64-70
  • 44 Beyarri AngelAlberich, Bonmati LuisMarti, Requena RobertoSanz. et al. In vivo trabecular bone morphologic and mechanical relationship using high resolution 3-T MRI. American Journal Roentgenology 2008; 191: 721-726
  • 45 Marie H, Lafage P, Boudignon B. et al. Glucocorticoid-induced osteoporosis: Pathophysological data and recent treatrments. Joint Bone Spine 2003; 70: 109-118
  • 46 Regidor DL, Kovesdy CP, Mehrotra R. et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. Journal of American Society of Nephrology 2008; 19: 2193-2203
  • 47 Lisk RD, Reuter LA. Dexamethasone: increased weights and decreased [3H] estradiol retention of uterus, vagina and pituitary in the ovariectomized rat. Endocrinology 1976; 99: 1063-1070
  • 48 Rasheed WI, Oraby FS, Hussein JS. Therapeutic efficacy of garlic oil with 1,25 dihydroxy vit D3 and calcium in osteoporotic ovariectomized rats. Australian. Journal Basic and Applied Science 2009; 3: 977-981
  • 49 William YWAu. Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture. Science 1976; 193: 1015-1017